
Colchicine, an anti-inflammatory drug, has shown promise in reducing the risk of major adverse cardiovascular events (MACE) in patients with established atherosclerotic disease or multiple cardiovascular risk factors.


coremsg

Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.

Evidence Builds to Support Colchicine in Treating ASCVD

colchicine-s-potential-in-reducing-cardiovascular-risks-emerging-evidence-and-clinical-implications


Colchicine's Potential in Reducing Cardiovascular Risks: Emerging Evidence and Clinical Implications
